Opportunities to improve health, production efficiency and sustainability through applied gene editing by Lightner, Jonathan E
    
National Institutes of Bioscience Journal 2016, Vol. 1    
http://www.nibjournal.ed.ac.uk/   http://dx.doi.org/10.2218/natlinstbiosci.1.2016.1741 
 
 
 
Genome Editing and the Future of Farming 
Conference held September 6th, 2016 at The Roslin Institute, Edinburgh 
 
 
Opportunities to improve health, production 
efficiency and sustainability through applied gene 
editing 
Jonathan E Lightner, Ph.D. 
Chief Scientific Officer 
Genus plc. 
 
Corresponding author: 
Jonathan.Lightner@genusplc.com 
 
 
 
 
 
The opinions expressed and arguments employed in this publication are the sole responsibility of the 
authors and do not necessarily reflect those of the OECD or of the governments of its Member countries.  
The Conference was sponsored by the OECD Co-operative Research Programme on Biological Resource 
Management for Sustainable Agricultural Systems, whose financial support made it possible for some of 
the invited speakers to participate in the Conference. 
2 
 
National Institutes of Bioscience Journal 2016, Vol. 1    
http://www.nibjournal.ed.ac.uk/   http://dx.doi.org/10.2218/natlinstbiosci.1.2016.1741 
 
Opportunities to improve health, production 
efficiency and sustainability through applied gene 
editing 
Jonathan E Lightner, Ph.D. 
Chief Scientific Officer 
Genus plc. 
 
Corresponding author: 
Jonathan.Lightner@genusplc.com 
 
ABSTRACT 
Recent advances in gene editing technologies and in the application of these technologies to 
livestock animals have created a wealth of opportunity for improving animal health and well-
being and thereby the sustainability of animal protein production.  I review two technology 
examples in porcine and bovine systems that Genus plc. is engaged in advancing.  In pigs, recent 
published work has demonstrated that a simple edit producing a loss of function variant for the 
gene product CD163 can produce full resistance to the devastating disease porcine 
reproductive and respiratory syndrome virus (PRRSv)1.  In cattle, a more subtle edit, involving 
an edit of the -5 amino acid before the signal cleavage site of the CD18 gene product from 
glutamine to glycine has been shown in cell model systems to confer resistance to the 
Mannheimia haemolytica leukotoxin2, and hypothesised to improve resilience to bovine 
respiratory disease (BRD).  Among other challenges, the development and successful 
commercialization of these types of gene editing technologies will require the creation of 
multiple, consistent, reproducible edits in commercial founder lines of elite genetics.  The 
practical challenges of deploying these technologies in beef, dairy and pork production systems 
are also considered. 
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INTRODUCTION 
As noted by other authors the relatively recent emergence of efficient gene editing reagents 
has created a resurgence in interest in livestock genome engineering3. Pigs4, cattle3 and sheep3 
have all be successfully gene edited and the range of genetic changes has progressed from loss 
of function variants5 to allele introgression within6 and across7 species.  Applications are rapidly 
advancing in the domain of improving animal health and well-being with published proof of 
concept results addressing high impact diseases like porcine reproductive and respiratory 
syndrome virus (PRRSv) in swine1, and day to day management challenges such as dehorning of 
dairy cattle6.  In addition to these results there are a number of research efforts ongoing to 
address multiple livestock health challenges. 
One of the most promising examples of the use of gene editing to positively impact livestock 
health is the recent demonstration that  gene edited pigs lacking the CD163 gene product are 
protected from infection by the PRRS virus1.  The disease (now called porcine reproductive and 
respiratory syndrome) was first recognised in the late 1980s and is characterised by rapid onset 
abortions and fertility loss as well as high mortality in young pigs and loss of productivity due to 
respiratory infections8.  Early in the 1990s a novel virus was isolated from infected sows and 
pigs in the Netherlands by Dutch scientists  termed the Lelystad virus9 and subsequently shown 
definitely to be the causal agent10.  Despite the isolation of and characterization of the virus, 
the disease has persisted and affects pork production in most parts of the globe11. The role of 
the porcine CD163 gene product in PRRSv infection has been reviewed by Welch and Calvert12 
in 2010.  Whitworth et al.l1 demonstrate convincingly that the CD163 gene product is required 
for infection in pigs and that pigs in which the gene product was missing, through gene editing 
with CRISPR/Cas913,behaved as fully resistant and displayed no observable phenotypic 
abnormalities1.   
Likewise in cattle, opportunities exist to improve animal health or resilience to disease through 
genome editing.  Bovine respiratory disease (BRD) is a complex, multifactorial disease involving 
multiple viral and bacterial factors14.  M. haemolytica is one of the main bacterial organisms 
isolated from cattle with BRD and is thought to be the major bacterial factor in BRD. A ruminant 
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specific leukotoxin has been identified as a principal component in the impact of the disease15.  
The uncleaved signal peptide of the bovine CD18 gene has been shown in cell system assays to 
be required for haemolysis to occur, and restoration of cleavage through engineering the 
introduction of a Q>G mutation can prevent haemolysis 2.  These authors hypothesise that 
introducing this change into cattle and other ruminants could improve the resilience of 
livestock to BRD2. This is a hypothesis we are pursuing at Genus plc.     
Clearly both these examples require further research and development to fully realise their 
potential in livestock, but in addition to the challenges of advancing these types of technologies 
at the molecular cellular and organismal levels, several additional systemic challenges have to 
be overcome for the successful commercialization of these types of technologies in modern 
livestock production systems.   
DISCUSSION 
Systemic challenges to commercially successful gene editing in livestock. 
In addition to the large challenges of simply discovering technologies, like those introduced 
above, which can benefit livestock, producers and society, there are challenges inherent to 
livestock production itself and to the application of genetic technologies in agriculture that 
deserve consideration.  Three of these challenges I will consider here are: technology 
regulation, technology acceptance and the production system expectations.   
TECHNOLOGY REGULATION  
Both the above cited examples can be produced with technologies that are collectively referred 
to today as “gene editing” and both can be realised at the commercial level in livestock without 
the introduction of DNA sequences from other species.  This distinguishes these types of 
genetic changes from the more widely available “transgenic” or “GM” technologies that are 
currently commercially ubiquitous in much of row crop agriculture in the Americas and are 
equally technically feasible16, though far less commercially impactful in livestock.  Gene editing, 
however, used in this context is quite new and the regulatory paradigm is evolving.  Delays in 
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clarity on the process by which regulation will occur can be more problematic and costly for 
technology development than the regulation process itself.  In the event that gene editing is 
regulated under the currently established paradigms for transgenic technologies, regulatory 
costs and regulatory processes will present unique challenges to the application in livestock.  As 
of November 2016, the United States Food and Drug Administration (FDA) has continued to 
state that it will regulate gene edited livestock under new animal drug provisions of the Federal 
Food Drug & Cosmetic Act17,18,19.  The costs of regulation and regulatory approvals for GM 
technologies are well studied and are now sufficiently mature to provide a useful expectation of 
what a modern regulatory dossier and approval process will likely entail.  A consultancy study 
published in 2011 by Phillips McDougal for CropLife International ("Cost Of Bringing A Biotech 
Crop To Market”20 puts the cost of regulatory science and regulatory engagement for a single 
GM crop product at $35 million USD.  This cost clearly sets a high bar for necessary economic 
value of a trait that is to be taken through the regulatory process and brought to market.  Costs 
of this scale are likely to be one reason why only very high value technologies are brought to 
market, and why they are brought so frequently, by enlarge, by multinational businesses with 
the economic resources necessary to bear these costs.  Less costly alternatives are being 
discussed in some jurisdictions and may positively impact the distribution of the benefits of 
gene editing technologies. 
TECHNOLOGY ACCEPTANCE 
Public acceptance, though potentially higher than for transgenics, remains a largely unexplored 
question.  Attitudes and interest in technology in food production, and in animal protein 
production specifically, vary greatly.  Regardless of their positions on specific practices many 
who work with livestock recognise that, with some variation by species and production system, 
people relate to livestock and livestock relate to people and it therefore is natural that concerns 
about technology use in animals is somewhat different than concerns about technology use in 
agricultural plants.  Genus is focusing its gene editing development efforts on targets with 
tangible benefits for livestock health and well-being, because in addition to the evident benefit 
for farmers and producers, we expect that these technologies, with tangible animal benefit, 
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may have higher acceptance among members of the public who take active interest in the 
production of their food and the well-being of animals involved in that production.   
THE CHALLENGES OF MODERN PRODUCER EXPECTATIONS 
Genetic improvement in livestock species has been going on for 100s of years but improvement 
towards specific economic outcomes with modern statistical tools originated in the mid-20th 
Century21.  Most recently, the application of genomic selection has further accelerated genetic 
gain and produced in many livestock systems a farmer expectation of continuous genetic 
improvement that requires resource and focus to deliver.  The impacts of genomic selection on 
the rate of genetic improvement in Holstein dairy cattle were recently reviewed by García-Ruiz 
et al.22.  They conclude that rates of genetic gain have improved dramatically across all traits 
with the largest impacts in lowly heritable traits18.  One common selection index for US dairy 
cattle profitability is the Net Merit Index (NM$)23 which has units in terms of US dollars.  Since 
the implementation of genomic selection NM$ of the average Holstein sire in stud in the US has 
increased markedly and at a rate exceeding 50NM$ per year.  In the PIC subsidiary of Genus 
plc., which has been improving porcine genetics for more than 40 years and implemented 
relationship based genomic selection across its lines in 2013 (Figure 1), the PIC index is a 
proprietary breeding index based on total economic value in pork production.  Rates of genetic 
improvement seen in our business since the implementation of genomic selection meet or 
exceed those seen in the dairy system.  The challenge presented for the successful introduction 
of a gene edit in both these genetic systems stems from the simple challenge of creating the 
edits in the most competitive germplasm available and disseminating those genetics before 
they are obsolete.  If, for example, we assume conservatively that PRRSv costs pork production 
on average 10% productivity per year, and we assume that PIC® genetics are improving at a rate 
of 5% per year, only two years of genetic lag would make introduction of the technology a 
break even proposition at the producer level, on average.  This challenge is further increased by 
the fact that PIC improves nine distinct lines which are combined through production pyramids 
to produce crossbred sows, and crossbred boars, which are then further bred to produce 
terminal pigs for meat production (Figure 2).  Because of the recessive nature of the resistance 
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phenotype, multiple edited pigs from the most elite genetics from multiple lines (in this 
example four) must be produced to create the possibility of having terminal pigs that are 
homozygous for the CD163 edit.  Clearly, the nature of regulation and the efficiency of editing 
processes will be important components in the ultimate overall success of delivery of these 
technologies.   
CONCLUSIONS 
The promise of gene editing to improve both animal health and thereby   farmers’ output and 
income, as well as the sustainability of animal protein production are evident.  These 
opportunities are closer to becoming a reality with the advent of facile gene editing 
technologies that allow precise and reproducible changes in animal genomes.  These 
technologies have led to rapid progress in the science that supports these technological 
opportunities and renewed interest in the commercial application of these technologies in 
livestock.  Success in the market place requires overcoming further challenges.  Creation of, and 
adherence to, a predictable, science-based regulatory process; advancing these technologies 
with appreciation for the sensitivity of the public to animal well-being in agriculture; and simply 
meeting farmer expectations on elite livestock performance in a world of continuous genetic 
improvement are all challenges that must be overcome for this promise to be realised. 
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Figure 1.  Relationship based genomic selection impact on rate of genetic improvement. 
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Figure 2.  Example of line complexity in commercial pork production. 
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